Guest guest Posted April 25, 2011 Report Share Posted April 25, 2011 News 5 new results for hepatitis c On the long, hard road to a breakthroughBoston Globe(Josh Reynolds for The Boston Globe) By Carolyn Y. CAMBRIDGE — Fifteen years ago, Boger received a call from a team of scientists one floor down at Vertex Pharmaceuticals Inc. who were searching for the key to hepatitis C, ...See all stories on this topic » Boston Globe Asia's problem with chronic hepatitisExaminer.comThese viruses constitute a major global health risk with around 350 million people being chronically infected with hepatitis B and around 170 million people being chronically infected with hepatitis C. According to the CDC, Hepatitis B is a contagious ...See all stories on this topic » Rearranging the Corporate DNABoston GlobeApproval for telaprevir — a drug aimed at curing hepatitis C — would hasten Vertex's transition from a research and development company that invested some $4 billion in drug discovery over the past two decades to an integrated research and commercial ...See all stories on this topic » Now comes the hard part: marketing an unknownBoston GlobeHe does admit it was a gamble to trade Merck & Co. for Vertex — and uproot his family — before telaprevir, Vertex's potential blockbuster drug to treat hepatitis C, has won approval from regulators. “There's some risk from a career perspective,'' ...See all stories on this topic » As science turns from chimp research, US wants to restart itKansas City StarCalling chimps crucial to advancing hepatitis C research, the NIH wants to ship them from the facility in New Mexico to the Texas Biomedical Research Institute in San . The director of the Texas institute's primate facility called chimps "a ...See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.